Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.6%
5Y CAGR+26.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+11.6%/yr
vs +54.5%/yr prior
5Y CAGR
+26.5%/yr
Recent deceleration
Acceleration
-42.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $52.74M | +14.8% |
| 2024 | $45.94M | +7.1% |
| 2023 | $42.90M | +12.9% |
| 2022 | $38.00M | +21.8% |
| 2021 | $31.20M | +91.3% |
| 2020 | $16.31M | +95.9% |
| 2019 | $8.33M | +24.8% |
| 2018 | $6.67M | - |